---
title: "ALT.US (ALT.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/ALT.US/news.md"
symbol: "ALT.US"
name: "ALT.US"
parent: "https://longbridge.com/en/quote/ALT.US.md"
datetime: "2026-05-21T18:21:30.558Z"
locales:
  - [en](https://longbridge.com/en/quote/ALT.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/ALT.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/ALT.US/news.md)
---

# ALT.US (ALT.US) — Related News

### [Altimmune | 10-Q: FY2026 Q1 Revenue Misses Estimate at USD 0](https://longbridge.com/en/news/286311863.md)
*2026-05-13T20:23:03.000Z*
### [Altimmune | 8-K: FY2026 Q1 Revenue Misses Estimate at USD 0](https://longbridge.com/en/news/286252827.md)
*2026-05-13T11:36:00.000Z*
### [Altimmune Announces First Quarter 2026 Financial Results and Business Update | ALT Stock News](https://longbridge.com/en/news/286255040.md)
*2026-05-13T03:30:00.000Z*
> Altimmune, Inc. announced its Q1 2026 financial results, reporting $535 million in cash and investments. The company pla

### [Altimmune to Present Results of Pemvidutide in MASH in an Oral Presentation and Multiple Poster Presentations at EASL Congress 2026 | ALT Stock News](https://longbridge.com/en/news/286250324.md)
*2026-05-13T03:20:29.000Z*
> Altimmune to Present Results of Pemvidutide in MASH in an Oral Presentation and Multiple Poster Presentations at EASL Co

### [Altimmune Announces Closing of $225 Million Oversubscribed Public Offering of Securities](https://longbridge.com/en/news/284201903.md)
*2026-04-27T11:00:00.000Z*
> Altimmune, Inc. has successfully closed a $225 million oversubscribed public offering, which includes 64.25 million shar

### [Altimmune, Inc. (NASDAQ:ALT) Receives Average Recommendation of "Moderate Buy" from Analysts](https://longbridge.com/en/news/284161797.md)
*2026-04-27T06:22:17.000Z*
> Altimmune, Inc. (NASDAQ:ALT) has received an average analyst rating of "Moderate Buy" from ten analysts. The stock has t

### [Altimmune Raises ~$211 Million in Stock-and-Warrant Offering Led by Leerink and Barclays](https://longbridge.com/en/news/284050212.md)
*2026-04-24T20:13:01.000Z*
> Altimmune has raised approximately $211 million through an underwriting agreement to sell 64.25 million shares of common

### [](https://longbridge.com/en/news/283859936.md)
*2026-04-23T14:56:03.000Z*
> Altimmune shares are trading lower after the company announced the pricing of its $225 million oversubscribed public off

### [Why Is Altimmune Stock Falling Today?](https://longbridge.com/en/news/283844394.md)
*2026-04-23T13:30:37.000Z*
> Altimmune's stock fell 10.66% to $3.10 following a $225 million public offering, raising dilution concerns as the compan